
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $396.5M | -- | -- | $0.97 | -- |
08/07/2025 | Q2 | $377.6M | -- | -- | $0.98 | -- |
05/07/2025 | Q1 | $348.2M | $358.9M | $0.79 | $0.95 | -$0.16 |
02/05/2025 | Q4 | $308.3M | $313.9M | $0.86 | $0.81 | $0.05 |
11/25/2024 | Q3 | $344M | $350.2M | $0.73 | $0.65 | $0.08 |
08/07/2024 | Q2 | $326.7M | $333.4M | $0.85 | $0.51 | $0.34 |
05/08/2024 | Q1 | $298.4M | $345.9M | $0.79 | $0.48 | $0.31 |
02/07/2024 | Q4 | $275.1M | $317.7M | $0.81 | $0.33 | $0.48 |
12/11/2023 | Q3 | -- | -- | $0.58 | $0.48 | $0.10 |
08/09/2023 | Q2 | -- | -- | $0.29 | $0.24 | $0.05 |
05/11/2023 | Q1 | -- | -- | $0.22 | $0.08 | $0.14 |
02/08/2023 | Q4 | -- | -- | -$0.35 | -$0.32 | -$0.03 |
12/12/2022 | Q3 | -- | -- | -$0.72 | $0.04 | -$0.76 |
08/10/2022 | Q2 | -- | -- | -$0.20 | -$0.05 | -$0.15 |
05/12/2022 | Q1 | -- | -- | -$0.38 | -$0.10 | -$0.28 |
02/09/2022 | Q4 | -- | -- | -$0.15 | -$0.29 | $0.14 |
12/15/2021 | Q3 | -- | -- | -$0.09 | $0.19 | -$0.28 |
08/12/2021 | Q2 | -- | -- | $0.16 | $0.39 | -$0.23 |
05/12/2021 | Q1 | -- | -- | -$0.02 | $0.08 | -$0.10 |
02/10/2021 | Q4 | -- | -- | -$0.06 | -- | -- |
12/16/2020 | Q3 | -- | -- | $0.44 | $0.35 | $0.09 |
08/12/2020 | Q2 | -- | -- | $0.05 | $0.15 | -$0.10 |
05/14/2020 | Q1 | -- | -- | -$0.02 | $0.24 | -$0.26 |
02/12/2020 | Q4 | -- | -- | -$0.02 | $0.02 | -$0.04 |
12/11/2019 | Q3 | -- | -- | $0.43 | $0.83 | -$0.40 |
08/07/2019 | Q2 | -- | -- | -- | $0.69 | -- |
05/09/2019 | Q1 | -- | -- | -- | $0.15 | -- |
02/06/2019 | Q4 | -- | -- | -- | -$0.03 | -- |
12/06/2018 | Q3 | -- | -- | -- | $0.70 | -- |
08/08/2018 | Q2 | -- | -- | -- | $0.65 | -- |
05/10/2018 | Q1 | -- | -- | -- | -- | -- |
02/07/2018 | Q4 | -- | -- | -- | -- | -- |
12/06/2017 | Q3 | -- | -- | -- | -- | -- |
08/03/2017 | Q2 | -- | -- | -- | -- | -- |
05/11/2017 | Q1 | -- | -- | -- | -- | -- |
02/09/2017 | Q4 | -- | -- | -- | -- | -- |
12/13/2016 | Q3 | -- | -- | -- | -- | -- |
08/04/2016 | Q2 | -- | -- | -- | -- | -- |
05/23/2016 | Q1 | -- | -- | -- | -- | -- |
02/09/2016 | Q4 | -- | -- | -- | -- | -- |
12/15/2015 | Q3 | -- | -- | -- | -- | -- |
Blue Bird reported $358.9M worth of top line sales in its most recent quarter.
Blue Bird announced earnings per share of $0.79 which represents a miss of analyst forecast a $0.95 per share.
Blue Bird reported $70.9M that represents $2.15 per share over the last quarter.
Blue Bird's earnings are forecast to grow from $3.16 per share to $3.35 per share next year representing an increase of 25.21%.
Blue Bird's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.